FNDC7
gene geneOn this page
Also known as FLJ35838
Summary
FNDC7 (fibronectin type III domain containing 7, HGNC:26668) is a protein-coding gene on chromosome 1p13.3, encoding Fibronectin type III domain-containing protein 7 (Q5VTL7).
Predicted to be located in extracellular region.
Source: NCBI Gene 163479 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 114 total
- MANE Select transcript:
NM_001144937
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26668 |
| Approved symbol | FNDC7 |
| Name | fibronectin type III domain containing 7 |
| Location | 1p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ35838 |
| Ensembl gene | ENSG00000143107 |
| Ensembl biotype | protein_coding |
| Entrez | 163479 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000370017, ENST00000445274, ENST00000932418
RefSeq mRNA: 1 — MANE Select: NM_001144937
NM_001144937
CCDS: CCDS44185
Canonical transcript exons
ENST00000370017 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001067176 | 108733272 | 108733532 |
| ENSE00001067177 | 108728632 | 108728886 |
| ENSE00001067178 | 108730674 | 108730928 |
| ENSE00001067184 | 108725750 | 108726004 |
| ENSE00001067186 | 108727808 | 108728065 |
| ENSE00001219160 | 108737495 | 108737524 |
| ENSE00001219202 | 108741773 | 108741841 |
| ENSE00001451521 | 108722335 | 108722592 |
| ENSE00001451522 | 108718789 | 108719049 |
| ENSE00001451523 | 108717777 | 108718031 |
| ENSE00001597830 | 108712908 | 108712996 |
| ENSE00001638834 | 108713511 | 108713529 |
| ENSE00002161413 | 108741925 | 108742749 |
Expression profiles
Bgee: expression breadth broad, 30 present calls, max score 60.18.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0263 / max 32.0524, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 4364 | 0.0263 | 3 |
Top tissues by expression
217 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| vastus lateralis | UBERON:0001379 | 60.18 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 59.99 | gold quality |
| quadriceps femoris | UBERON:0001377 | 59.74 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 59.40 | gold quality |
| buccal mucosa cell | CL:0002336 | 58.89 | gold quality |
| biceps brachii | UBERON:0001507 | 58.39 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 56.78 | gold quality |
| parotid gland | UBERON:0001831 | 56.60 | gold quality |
| endothelial cell | CL:0000115 | 56.37 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 56.06 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 55.63 | gold quality |
| myocardium | UBERON:0002349 | 54.41 | gold quality |
| jejunal mucosa | UBERON:0000399 | 54.11 | gold quality |
| sperm | CL:0000019 | 51.88 | gold quality |
| heart right ventricle | UBERON:0002080 | 51.70 | gold quality |
| oocyte | CL:0000023 | 51.17 | gold quality |
| parietal pleura | UBERON:0002400 | 50.77 | gold quality |
| jejunum | UBERON:0002115 | 50.64 | gold quality |
| visceral pleura | UBERON:0002401 | 50.35 | gold quality |
| upper leg skin | UBERON:0004262 | 49.02 | silver quality |
| substantia nigra pars compacta | UBERON:0001965 | 48.50 | gold quality |
| deltoid | UBERON:0001476 | 48.18 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 47.03 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 46.10 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 45.94 | gold quality |
| left testis | UBERON:0004533 | 45.52 | gold quality |
| amniotic fluid | UBERON:0000173 | 45.42 | gold quality |
| muscle tissue | UBERON:0002385 | 45.41 | gold quality |
| testis | UBERON:0000473 | 45.32 | gold quality |
| globus pallidus | UBERON:0001875 | 44.76 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.55 |
Regulation
Is transcription factor: no
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | fndc7a | ENSDARG00000077096 |
| danio_rerio | ENSDARG00000108006 | |
| mus_musculus | Fndc7 | ENSMUSG00000045326 |
| rattus_norvegicus | Fndc7 | ENSRNOG00000020421 |
Paralogs (25): TNC (ENSG00000041982), FCN1 (ENSG00000085265), ANGPT2 (ENSG00000091879), ANGPT4 (ENSG00000101280), FGL1 (ENSG00000104760), FN1 (ENSG00000115414), TNR (ENSG00000116147), ANGPTL1 (ENSG00000116194), TNN (ENSG00000120332), FGL2 (ENSG00000127951), FIBCD1 (ENSG00000130720), ANGPTL6 (ENSG00000130812), ANGPTL3 (ENSG00000132855), ANGPTL2 (ENSG00000136859), FCN3 (ENSG00000142748), ANGPT1 (ENSG00000154188), FCN2 (ENSG00000160339), MFAP4 (ENSG00000166482), ANGPTL4 (ENSG00000167772), TNXB (ENSG00000168477), FGG (ENSG00000171557), FGA (ENSG00000171560), FGB (ENSG00000171564), ANGPTL7 (ENSG00000171819), ANGPTL5 (ENSG00000187151)
Protein
Protein identifiers
Fibronectin type III domain-containing protein 7 — Q5VTL7 (reviewed: Q5VTL7)
All UniProt accessions (2): Q5VTL7, H7C2H6
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
RefSeq proteins (1): NP_001138409* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003961 | FN3_dom | Domain |
| IPR013783 | Ig-like_fold | Homologous_superfamily |
| IPR036116 | FN3_sf | Homologous_superfamily |
Pfam: PF00041
UniProt features (18 total): domain 8, sequence variant 4, glycosylation site 2, sequence conflict 2, signal peptide 1, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5VTL7-F1 | 86.58 | 0.51 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 230, 433
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 45 (showing top):
GCANCTGNY_MYOD_Q6, TGACCTY_ERR1_Q2, YY1_02, BASAKI_YBX1_TARGETS_DN, WGTTNNNNNAAA_UNKNOWN, MTOR_UP.V1_UP, NABA_ECM_GLYCOPROTEINS, MIR6867_5P, GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN, MIR6768_3P, MIR4795_5P, MIR4764_5P, MIR4712_3P, MIR3650, PBX1_01
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
196 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FNDC7 | FNDC10 | F2Z333 | 616 |
| FNDC7 | CLEC19A | Q6UXS0 | 589 |
| FNDC7 | ZPLD1 | Q8TCW7 | 523 |
| FNDC7 | EEIG2 | Q5T8I3 | 506 |
| FNDC7 | TMEM167B | Q9NRX6 | 475 |
| FNDC7 | WDR47 | O94967 | 435 |
| FNDC7 | FANK1 | Q8TC84 | 423 |
| FNDC7 | FRMD8 | Q9BZ67 | 419 |
| FNDC7 | FUBP3 | Q96I24 | 417 |
| FNDC7 | ICE2 | Q659A1 | 405 |
| FNDC7 | SNX7 | Q9UNH6 | 401 |
| FNDC7 | IGFN1 | Q86VF2 | 380 |
| FNDC7 | LRFN5 | Q96NI6 | 372 |
| FNDC7 | PRPF38B | Q5VTL8 | 369 |
| FNDC7 | F2RL3 | Q96RI0 | 368 |
IntAct
0 interactions, top by confidence:
BioGRID (3): FNDC7 (Affinity Capture-MS), FNDC7 (Affinity Capture-RNA), FNDC7 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A2AED3, B0CLX4, B2RU80, B3DK56, B3EX02, E2RK30, F1NWE3, O14522, O70458, O70535, O88488, P08922, P08941, P08F94, P0C5E4, P17948, P20352, P23467, P28827, P28828, P35822, P35969, P35992, P42702, P42703, P53767, P97378, Q15262, Q2EY13, Q2EY15, Q2VWP7, Q2VWP9, Q589G5, Q5RFR6, Q5VJ70, Q5VTL7, Q5XNR9, Q62959, Q63132, Q65Z14
Diamond homologs: A2AED3, Q5VTL7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
114 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 103 |
| Likely benign | 9 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1745 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:108718787:A:AG | acceptor_gain | 1.0000 |
| 1:108718788:G:GA | acceptor_gain | 1.0000 |
| 1:108718788:GT:G | acceptor_gain | 1.0000 |
| 1:108719050:G:GG | donor_gain | 1.0000 |
| 1:108725872:G:GT | donor_gain | 1.0000 |
| 1:108725872:G:T | donor_gain | 1.0000 |
| 1:108718787:AGT:A | acceptor_gain | 0.9900 |
| 1:108718788:GTG:G | acceptor_gain | 0.9900 |
| 1:108718788:GTGT:G | acceptor_gain | 0.9900 |
| 1:108718788:GTGTT:G | acceptor_gain | 0.9900 |
| 1:108719046:ACAA:A | donor_gain | 0.9900 |
| 1:108719049:AG:A | donor_loss | 0.9900 |
| 1:108719050:G:T | donor_loss | 0.9900 |
| 1:108719051:T:G | donor_loss | 0.9900 |
| 1:108725915:C:G | donor_gain | 0.9900 |
| 1:108727884:T:TA | acceptor_gain | 0.9900 |
| 1:108730672:A:G | acceptor_gain | 0.9900 |
| 1:108741771:A:AG | acceptor_gain | 0.9900 |
| 1:108741771:AGT:A | acceptor_gain | 0.9900 |
| 1:108741772:G:GG | acceptor_gain | 0.9900 |
| 1:108741772:GT:G | acceptor_gain | 0.9900 |
| 1:108741772:GTG:G | acceptor_gain | 0.9900 |
| 1:108718989:GCC:G | donor_gain | 0.9800 |
| 1:108719047:CAA:C | donor_gain | 0.9800 |
| 1:108725748:A:AG | acceptor_gain | 0.9800 |
| 1:108725749:G:GG | acceptor_gain | 0.9800 |
| 1:108725835:C:G | donor_gain | 0.9800 |
| 1:108725915:C:CG | donor_gain | 0.9800 |
| 1:108733494:G:GT | donor_gain | 0.9800 |
| 1:108741842:G:GG | donor_gain | 0.9800 |
AlphaMissense
4750 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:108727872:G:C | W392C | 0.990 |
| 1:108727872:G:T | W392C | 0.990 |
| 1:108727870:T:A | W392R | 0.987 |
| 1:108727870:T:C | W392R | 0.987 |
| 1:108717839:T:A | W49R | 0.984 |
| 1:108717839:T:C | W49R | 0.984 |
| 1:108725971:A:C | S360R | 0.982 |
| 1:108725973:T:A | S360R | 0.982 |
| 1:108725973:T:G | S360R | 0.982 |
| 1:108725812:T:A | W307R | 0.981 |
| 1:108725812:T:C | W307R | 0.981 |
| 1:108725814:G:C | W307C | 0.981 |
| 1:108725814:G:T | W307C | 0.981 |
| 1:108717841:G:C | W49C | 0.980 |
| 1:108717841:G:T | W49C | 0.980 |
| 1:108718848:T:A | W133R | 0.980 |
| 1:108718848:T:C | W133R | 0.980 |
| 1:108718977:T:G | Y176D | 0.978 |
| 1:108718850:G:C | W133C | 0.975 |
| 1:108718850:G:T | W133C | 0.975 |
| 1:108717942:T:C | L83P | 0.971 |
| 1:108733326:G:C | R645P | 0.969 |
| 1:108733336:G:C | W648C | 0.967 |
| 1:108733336:G:T | W648C | 0.967 |
| 1:108733511:T:C | C707R | 0.967 |
| 1:108733460:T:G | Y690D | 0.966 |
| 1:108718984:T:A | I178K | 0.963 |
| 1:108733374:T:C | L661P | 0.962 |
| 1:108728696:G:C | W478C | 0.960 |
| 1:108728696:G:T | W478C | 0.960 |
dbSNP variants (sampled 300 via entrez): RS1000078062 (1:108722043 A>G), RS1000139608 (1:108732173 C>T), RS1000256864 (1:108739821 T>C), RS1000284737 (1:108740050 A>G,T), RS1000439215 (1:108733011 C>A,T), RS1000808795 (1:108732693 T>C), RS1000854563 (1:108714659 C>T), RS1001112678 (1:108720805 C>T), RS1001233561 (1:108725996 A>G,T), RS1001269360 (1:108738153 A>G), RS1001290550 (1:108738615 A>T), RS1001337532 (1:108731247 G>A), RS1001502529 (1:108713045 A>T), RS1001563956 (1:108722174 A>G), RS1001838591 (1:108727477 G>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| 2-methyl-4-isothiazolin-3-one | increases expression | 1 |
| potassium chromate(VI) | affects cotreatment, increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression | 1 |
| epigallocatechin gallate | affects cotreatment, increases expression | 1 |
| bisphenol S | decreases methylation | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Lead | decreases expression | 1 |
| Lipopolysaccharides | affects response to substance, increases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Permethrin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.